153 related articles for article (PubMed ID: 37689632)
1. Circulating choline levels are associated with prognoses in patients with pulmonary hypertension: a cohort study.
Yang Y; Yang B; Liu B; Liang Y; Luo Q; Zhao Z; Liu Z; Zeng Q; Xiong C
BMC Pulm Med; 2023 Sep; 23(1):313. PubMed ID: 37689632
[TBL] [Abstract][Full Text] [Related]
2. Higher circulating Trimethylamine N-oxide levels are associated with worse severity and prognosis in pulmonary hypertension: a cohort study.
Yang Y; Yang B; Li X; Xue L; Liu B; Liang Y; Zhao Z; Luo Q; Liu Z; Zeng Q; Xiong C
Respir Res; 2022 Dec; 23(1):344. PubMed ID: 36517838
[TBL] [Abstract][Full Text] [Related]
3. Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension.
Yang Y; Xu J; Shu S; Wang P; Liang Y; Liu B; Yang B; Zhang H; Zhao Q; Zhao Z; Luo Q; Liu Z; Zeng Q; Xiong C
BMC Pulm Med; 2024 Jan; 24(1):35. PubMed ID: 38229103
[TBL] [Abstract][Full Text] [Related]
4. High Betaine and Dynamic Increase of Betaine Levels Are Both Associated With Poor Prognosis of Patients With Pulmonary Hypertension.
Yang Y; Xu J; Zhou J; Xue J; Gao J; Li X; Sun B; Yang B; Liu Z; Zhao Z; Luo Q; Zeng Q; Zheng L; Xiong C
Front Cardiovasc Med; 2022; 9():852009. PubMed ID: 35433890
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
6. [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].
Liu XQ; Yan H; Qiu JX; Zhang CY; Qi JG; Zhang X; Xiao HJ; Yang YL; Chen YH; Du JB
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):768-777. PubMed ID: 29045954
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Yaylalı YT; Yağmur B; Sinan ÜY; Meriç M; Başarıcı İ; Kılıçkıran Avcı B; Şenol H; Nalbantgil S; Küçükoğlu S; Öngen Z
Anatol J Cardiol; 2023 Aug; 27(8):479-485. PubMed ID: 37288853
[TBL] [Abstract][Full Text] [Related]
8. High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension.
Yang Y; Zeng Q; Gao J; Yang B; Zhou J; Li K; Li L; Wang A; Li X; Liu Z; Luo Q; Zhao Z; Liu B; Xue J; Jiang X; Konerman MC; Zheng L; Xiong C
Eur Heart J Open; 2022 Sep; 2(5):oeac021. PubMed ID: 36071697
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
10. Circulating metabolites from the choline pathway and acute coronary syndromes in a Chinese case-control study.
Dai Y; Tian Q; Si J; Sun Z; Shali S; Xu L; Ren D; Chang S; Dong X; Zhao H; Mei Z; Zheng Y; Ge J
Nutr Metab (Lond); 2020; 17():39. PubMed ID: 32489394
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry.
Hartopo AB; Anggrahini DW; Dinarti LK; Schäfer AK; Bergmann A; Fachiroh J; Somma SD
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109706
[TBL] [Abstract][Full Text] [Related]
12. Targeted proteomics of right heart adaptation to pulmonary arterial hypertension.
Amsallem M; Sweatt AJ; Arthur Ataam J; Guihaire J; Lecerf F; Lambert M; Ghigna MR; Ali MK; Mao Y; Fadel E; Rabinovitch M; de Jesus Perez V; Spiekerkoetter E; Mercier O; Haddad F; Zamanian RT
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33334941
[TBL] [Abstract][Full Text] [Related]
13. Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
Zhang Q; Zhu F; Shi G; Hu C; Zhang W; Huang P; Zhu C; Gu H; Yang D; Li Q; Niu Y; Chen H; Ma R; Pan Z; Miao H; Zhang X; Li G; Tang Y; Qiao G; Yan Y; Zhu Z; Zhang H; Han F; Li Y; Lin J; Chen H
Circulation; 2023 Feb; 147(7):549-561. PubMed ID: 36780387
[TBL] [Abstract][Full Text] [Related]
14. Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.
Dong X; Shi Y; Xia Y; Zhang X; Qian J; Zhao J; Peng J; Wang Q; Weng L; Li M; Du B; Zeng X
BMC Pulm Med; 2022 Aug; 22(1):295. PubMed ID: 35909128
[TBL] [Abstract][Full Text] [Related]
15. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
Prins KW; Rose L; Archer SL; Pritzker M; Weir EK; Olson MD; Thenappan T
J Am Heart Assoc; 2019 Jan; 8(2):e011464. PubMed ID: 30646788
[TBL] [Abstract][Full Text] [Related]
16. Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
Yoshihisa A; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Takeishi Y
ESC Heart Fail; 2019 Apr; 6(2):291-296. PubMed ID: 30681298
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
Sugimoto K; Yoshihisa A; Nakazato K; Jin Y; Suzuki S; Yokokawa T; Misaka T; Yamaki T; Kunii H; Suzuki H; Saitoh SI; Takeishi Y
PLoS One; 2016; 11(11):e0165603. PubMed ID: 27875533
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
19. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
[TBL] [Abstract][Full Text] [Related]
20. Fractional Exhaled Nitric Oxide Measurement in Pulmonary Hypertension: A Follow-Up Study.
Akbay NO; Bingol Z; Kiyan E; Karaayvaz EB; Bilge AK; Issever H; Okumus G
Clin Appl Thromb Hemost; 2018 Apr; 24(3):483-488. PubMed ID: 28393619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
